Announced
Completed
Financials
Sources
Tags
bio-transformation
Single Bidder
Acquisition
Friendly
Germany
Biotechnology
Majority
Private
Completed
biotechnology innovation
optimising bio-processing
Cross Border
Synopsis
Kerry Group, a global taste and nutrition company, completed the acquisition of a 92% stake in c-LEcta, a biotechnology innovation company, specialising in precision fermentation, optimised bio-processing, and bio-transformation, for €137m. "We are very happy to join Kerry group and their global presence in the food and pharmaceutical sectors gives us access to additional markets. At the same time, their expertise in ingredient technologies and applications is a perfect fit as we continue to drive our growth potential in the future. We will continue to collaborate with our existing industry partners and will of course continue to produce and distribute our products for our valued customers,” Marc Struhalla, c-LEcta Founder and CEO.
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.